Date: 1.12.2014
When a medication enters the bloodstream, it ends up being concentrated in the liver – after all, one of the organ's main functions is to cleanse the blood. This means that if a drug is going to have an adverse effect on any part of the body, chances are it will be the liver.
It would seem to follow, therefore, that if a pharmaceutical company wanted to test the safety of its products, it would be nice to have some miniature human livers on which to experiment – which is just what San Diego-based biotech firm Organovo is about to start selling.
Known as exVive3D, the three-dimensional liver models measure just a few millimeters across, and are created using a 3D bioprinter. The device incorporates two print heads, one of which deposits a support matrix, and the other of which precisely places human liver cells in it.
The resulting models are composed of living human liver tissue, and incorporate hepatocytes, stellate, and endothelial cells – just like a real, full-sized liver. They also produce liver proteins such as albumin, fibrinogen and transferrin, plus they synthesize cholesterol.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Nature Biotechnology - Biotechnology at Nature.com server.
Science Magazine
Tiny skin-stabbing stars designed to get meds through the epidermis
A roadmap for using viruses to enhance crop performance